Equibles does not estimate personal net worth.
Get an email with a short summary when Protara Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TARA alertsPatrick Fabbio is recorded as CFO at Protara Therapeutics, Inc. (TARA). The newest filing on record that lists Patrick Fabbio as CFO at Protara Therapeutics, Inc. (TARA) is dated April 28, 2026. Protara Therapeutics, Inc. reported in an 8-K filed January 30, 2023 that Patrick Fabbio was appointed Chief Financial Officer, effective January 30, 2023. The proxy statement of Protara Therapeutics, Inc. reports total compensation of $1,023,536 for Patrick Fabbio in fiscal 2024, including a base salary of $464,967. Disclosed compensation is on record for 2 fiscal years. Patrick Fabbio has spoken on 1 investor event across 1 company, most recently for Protara Therapeutics, Inc. on September 15, 2026. Protara Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Protara Therapeutics, Inc. includes Jesse Shefferman (CEO and Board Member), Luke Beshar (Chairman), Blaine Davis (CFO) and 7 others.
“On January 30, 2023, Protara Therapeutics, Inc. (the “Company”) announced that, effective as of January 30, 2023, Patrick Fabbio had been appointed as Chief Financial Officer of the Company.”
“Happy to be here to walk you through our exciting programs at Protara. Please note, I'll make some remarks today that include forward-looking statements that involve some risks and uncertainties.”
Start not stated–present
Last confirmed April 28, 2026
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Protara Therapeutics, Inc. (TARA) | Chief Financial Officer | $464,967 | $1,023,536 |
| 2023 | Protara Therapeutics, Inc. (TARA) | Chief Financial Officer | $412,875 | $1,443,529 |
